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Antimicrobial peptides (AMPs) are natural antibiotics produced by various organisms
such as mammals, arthropods, plants, and bacteria. In addition to antimicrobial activity,
AMPs can induce chemokine production, accelerate angiogenesis, and wound healing and
modulate apoptosis in multicellular organisms. Originally, their antimicrobial mechanism of
actionwas thought to consist solely of an increase in pathogen cell membrane permeability,
but it has already been shown that several AMPs do not modulate membrane permeability
in the minimal lethal concentration. Instead, they exert their effects by inhibiting processes
such as protein and cell wall synthesis, as well as enzyme activity, among others.
Although resistance to these molecules is uncommon several pathogens developed
different strategies to overcome AMPs killing such as surface modiﬁcation, expression of
efﬂux pumps, and secretion of proteases among others. This review describes the various
mechanisms of action of AMPs and how pathogens evolve resistance to them.
Keywords: antimicrobial peptides, mechanism of action, mechanism of resistance, bacterial, membrane
permeability and intracellular targets
ANTIMICROBIAL PEPTIDES
Antimicrobial peptides (AMPs), an important part of the innate
immune system, are small molecules that may present antibac-
terial, antifungal, antiparasitic, and antiviral activity (Hancock
and Diamond, 2000; Jenssen et al., 2006). Usually these molecules
are composed of 10–50 amino-acid residues, and arranged in dif-
ferent groups depending on the amino-acid composition, size,
and conformation (Lai and Gallo, 2009; Nakatsuji and Gallo,
2012).
The largest group corresponds to cationic peptides, which is
divided in three classes (Vizioli and Salzet, 2002; Brogden, 2005).
The ﬁrst class is composed by linear cationic α-helical peptides,
such as Magainin and Cecropins that are linear before their inter-
action with the cell membrane, and then adopt an amphipathic
α-helical secondary structure (Bechinger et al., 1993). The second
class comprises cationic peptides enriched for speciﬁc amino acids
like proline, arginine, and other residues. These peptides are linear,
although some may exhibit extended coils (Brogden, 2005). The
third class includes cationic peptides that contain cysteine residues
and form disulphide bonds and stable β-sheets. Defensins, an
example of this class, have six cysteine residues and are divided
according to the alignment of their disulphide bridges (α-, β-, and
θ-defensin) (Mehra et al., 2012).
Other groups of AMPs are described as non-cationic peptides,
anionic peptides, aromatic peptides, and peptides derived from
oxygen-binding proteins (Vizioli and Salzet, 2002). Just as the
cationic peptides, anionic peptides (AAMP) are also an important
part of the innate immune system and have been identiﬁed in ver-
tebrates, invertebrates, and plants (Harris et al., 2009). Although
the antibacterial activity of these peptides is considered weak, they
could improve the activity of cationic peptides (Vizioli and Salzet,
2002).
Different studies revealed that besides peptide charge (cationic
or anionic), other characteristics such as size, primary sequence,
conformation, structure, hydrophobicity, and amphipathicity
could be essential for antimicrobial activity and mechanism of
action (Friedrich et al., 2000; Gennaro and Zanetti, 2000).
MAIN MECHANISMS OF ACTION
The classic action mechanism of AMPs involves their ability to
cause cell membrane damage. AMPs can interact with microor-
ganisms by electrostatic forces between their positive amino acid
residues and negative charges exposed on cell surfaces. It has
been suggested that the composition of cell surface drives the
speciﬁcity of AMPs. In this sense, the sensitivity of prokaryotic
and eukaryotic cells is directly related to the different physico-
chemical properties of the lipids found on both cell membranes
(Dathe and Wieprecht, 1999; Matsuzaki, 1999). In mammalian
membranes, the lipids most commonly found on the extracellular
side of the bilayer are neutral phospholipids such as phosphatidyl-
choline and sphingomyelin. On the other hand, the bacterial cell
membrane is essentially composed by negatively charged lipids,
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such as phosphatidylglycerol (PG), cardiolipin, and the zwit-
ter ionic phosphatidylethanolamine (PE) (Lohner, 2009). The
overall negative charge found on the membrane of bacteria has
an important role in the preferential binding of some peptides
to those microorganisms. Moreover, Gram-negative bacteria con-
tain lipopolysaccharides (LPS) on their outer membrane, and the
cell wall of Gram-positive bacteria is enriched in acidic polysac-
charides (teichoic and teichuronic acids). Those molecules that
confer a negative charge to the bacterial surface were selected as
targets for cationic AMPs (Brogden, 2005).
The interaction and action of AMPs with their target cells
depends largely on the cell surface as well as on the amino
acid composition of these peptides. This idea is supported by
the high conservation of positively charged amino acid residues
among peptides sequences from various organisms (Yeaman and
Yount, 2003). In addition, the secondary structure adopted by the
peptide is essential for the binding to negatively charged com-
pounds in the target membrane, such as anionic phospholipids
(Matsuzaki, 2009). Depending on the peptide/lipids ratios and
afﬁnity, these peptide molecules can be oriented perpendicularly,
allowing their insertion into the lipid bilayer and the formation
of transmembrane pores (Brogden, 2005; Melo and Castanho,
2012).
The mechanisms by which AMPs can traverse microbial mem-
branes are not common to all peptides and seem to depend on the
molecular properties of both, peptide addressed and lipid mem-
brane composition. Several membrane defects can be induced by
AMPs, among them we can highlight formation of pores, phase
separation, and promotion of non-lamellar lipid structure or dis-
ruption of the membrane bilayer (Lohner and Prenner, 1999).
Some models that may explain membrane disruption by AMPs
have been proposed, such as barrel-stave, toroidal, and carpet
models.
The ﬁrst mechanism proposed, the “barrel-stave” model, sug-
gests that peptides form transmembrane pores by their direct
insertion into the lipid core of the target membrane (Ehrenstein
and Lecar, 1977). In this model, AMP binds to the membrane
surface as a monomer, which is followed by their oligomerization
and pore formation. The recruitment of additional monomers
can increase the pore size, allowing cytoplasmic content leaking
with subsequent cell death. In this mechanism, peptide sec-
ondary structures, such as hydrophobic α-helix and/or β-sheet,
are essential to pore formation (Breukink and de Kruijff, 1999).
These peptide regions interact with the membrane lipids, while
the hydrophilic peptide regions form the lumen of the channel
(Brogden, 2005).
In contrast to the “barrel-stave”model, in the “toroidal”model,
peptide molecules are inserted into the membrane forming a bun-
dle, inducing the lipid monolayers to continuously bend through
the pore (Yang et al., 2001). As a consequence, membrane lipids
become interspersed with peptides forming the pore (Yeaman
and Yount, 2003). Examples of AMPs toroidal pore forming are
megainins, protegrins, and melittin (Brogden, 2005).
According to the “carpet” model, AMPs cover the membrane
surface affecting its architecture, in a detergent-like manner
(Rotem andMor, 2009). Their interaction is ﬁrst driven by electri-
cal attraction and, when the amount of AMPs on the membrane
surface reaches a threshold concentration, the membrane disin-
tegrates, leading to cell lysis (Oren and Shai, 1998). However, it
was described that some peptides might also form transmem-
brane pores at concentrations below the threshold, suggesting
that the mechanism by which the peptide disrupts/permeates the
membrane depends on its concentration (Lohner, 2009).
Although most AMPs interact directly with cell membrane
lipids, it was reported that some peptides might require a bac-
terial receptor. This hypothesis was supported by the fact that
the antimicrobial activities of the all-L and all-D enantiomers of
some peptides, such as apidaecin and drosocin, are not the same
(Casteels and Tempst, 1994; Bulet et al., 1996).
More recently it has been proposed that AMP driven microbial
death can be caused by others mechanisms in addition to mem-
brane disruption, followed by cell lysis. Many evidences indicate
that some AMPs can interact with intracellular targets inducing
cell damages, such as the inhibition of cell wall, DNA, RNA, and
protein synthesis (Brogden, 2005; Straus andHancock, 2006). Fur-
thermore, one peptide can act uponmultiple cell targets, involving
a mixed multi-hit mechanism (Jenssen et al., 2006; Straus and
Hancock, 2006). Finally, it is important to note that AMPs action
may vary according to test conditions and can be inﬂuenced by
external factors such as media pH, osmolarity, and temperature
(Yeaman and Yount, 2003).
INTRACELLULAR TARGETS
INHIBITION OF CELL WALL SYNTHESIS
The cell wall is an essential bacterial structure responsible for the
cell shape. Additionally, the cell wall prevents cell lysis due the high
cytoplasmic osmotic pressure and allows the anchoring of mem-
brane components and extracellular proteins, such as adhesins. In
Gram-positive organisms, the main component of the cell wall is
the peptidoglygan, present in multiple layers. In Gram-negative
bacteria, an outer membrane, composed mainly by LPS, overlaps
a thin layer of peptidoglycan. Since peptidoglycan is not found
in eukaryotic cells, compounds that inhibit its synthesis are inter-
esting targerts for therapeutics. In particular, lipid II, which is an
important precursor of peptidoglycan synthesis, was shown to be
an attractive target of antibacterial compounds, such as several
lantibiotics (de Kruijff et al., 2008; Yount and Yeaman, 2013).
Class I bacteriocins, also known as lantibiotics, are a family
of AMPs ribosomally synthesized and post-translationally pro-
cessed to produce numerous molecules with unusual modiﬁed
residues (Yount andYeaman, 2013). Besides killing bacteria by tar-
geting lipid II, and consequently inhibiting cell wall biosynthesis,
it has been described that the lantibiotics can also form trans-
membrane pores, that allows the efﬂux of molecules and/or ions
– ATP, K+, and PO43−(Islam et al., 2012). Several studies have
demonstrated that nisin, an antimicrobial peptide widely used in
food industry, ﬁrst binds to lipid II and then acts by forming pores
in the membrane, with consequent loss of amino acids, K+, and
ATP by the cell (Yount and Yeaman, 2013). A recent study also
demonstrated that nisin binds to lipids III and IV, interfering with
teichoic and lipoteichoic acids biosynthesis (Muller et al., 2012).
In addition, nisin appears to stimulate the activity of the autolysin
N-acetylmuramoyl-L-alanine amidase, as shown in Staphylococcus
simulans. Similar stimulatory effect on this autolysin activity was
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observed using Pep5, an antimicrobial peptide produced by S. epi-
dermidis (Bierbaum and Sahl, 1987). The induction of autolysins
might result in cell wall damage, leading to lysis and subsequent
cell death.
Mersacidin, another well-characterized lantibiotic, is effective
against methicillin-resistant S. aureus (MRSA) in a murine infec-
tion model (Chatterjee et al., 1992; Kruszewska et al., 2004). The
binding site of mersadicin to lipid II differs from that described
for nisin: while nisin binds to the phosphate, mersacidin proba-
bly binds to sugar residues. Despite of the different binding sites,
bothAMPs inhibit the formation of the peptidoglycan (Brotz et al.,
1998;Islam et al., 2012).
Another group of lantibiotics is the two-peptide family, whose
members are composed by two independently transcribed pep-
tides that act synergistically in order to have an optimal antimi-
crobial activity (Lawton et al., 2007; Yount and Yeaman, 2013). It
has been proposed that one of the peptides binds to lipid II while
the other forms transmembrane pores (Wiedemann et al., 2006).
Lacticin 3147, staphylococcin C55, plantaricinW, and haloduracin
are examples of the two-peptide lantibiotic family (Lawton et al.,
2007).
In addition to lantibiotics, other AMPs target the cell-wall syn-
thesis. Lcn972, is a representative of class II bacteriocins that
probably exerts an antimicrobial activity via binding lipid II,
diverging from the most of other peptides from its class, that
act preferentially via membrane disruption. Similarly, nonribo-
somally synthesized peptides, such as vancomycin, daptomycin,
telavancin, and dalbavancin, aswell as somedefensins produced by
eukaryotic organisms, target lipid II biosynthesis pathway, acting
via a cell-wall inhibitory mechanism (Yount and Yeaman, 2013).
Because of the main role of bacterial cell wall in cell
integrity, as well as its absence in mammalian cells, this structure
becomes an excellent target in the search of new antimicro-
bial drugs. Moreover, the combinatory mechanisms of cell wall
synthesis inhibition and cell membrane disruption observed
for some AMPs could minimize the emergence of resistant
microorganisms.
INHIBITION OF NUCLEIC ACID AND PROTEIN SYNTHESIS
Some AMPs can spontaneously traverse bacterial outer and inner
membranes, targeting intracellularmolecules such as nucleic acids
and proteins. Buforin II, a 21 amino acid, cationic and linear
molecule, is an example of an AMP able to cross the cell mem-
brane without permeabilizing it, which later accumulates in the
cytoplasm (Cho et al., 2009).
It is well known that this peptide has a proline hinge (Pro11)
that plays a critical role in promoting the peptide penetration
into the cell (Cho et al., 2009; Xie et al., 2011). Once in the
cytoplasm, buforin II binds to DNA and RNA, as showed for
Escherichia coli (Park et al., 1998). The strong afﬁnity of this pep-
tide for nucleic acids in vitro (Park et al., 1998) might be explained
by the sequence identity between buforin II and the N-terminal
region of histone H2A (Cho et al., 2009). Curiously, buforin II
has an antiendotoxin activity (Giacometti et al., 2002). The signif-
icant reduction of endotoxin plasmatic levels mediated by buforin
II is remarkable since the endotoxin released in Gram-negative
infections is responsible for strong inﬂammatory reactions, with
the production of tissue-damaging cytokines, resulting in mul-
tiple organ failure and, sometimes, host lethality (septic shock
syndrome). The capability to neutralize the toxic effects of endo-
toxin, preventing the septic shock, has been described for many
other AMPs, such as temporins (Mangoni and Shai, 2009) and
cathelicidins (Mookherjee et al., 2007).
Many other AMPs act by inhibiting nucleic acid synthesis.
Indolicidin, one of the smallest natural cationic peptide, appears to
act promoting signiﬁcant membrane depolarization and inhibit-
ing DNA synthesis (Subbalakshmi and Sitaram, 1998; Nan et al.,
2009). As a consequence of the inhibitory effect on DNA synthe-
sis, indolicidin induces ﬁlamentation of E. coli cells (Subbalakshmi
and Sitaram, 1998).
Puroindoline, similarly to indolicidin, is a family of peptides
rich in tryptophan residues, that also act by inhibiting DNA syn-
thesis. Haney et al. (2013), using radioactive precursors for DNA,
RNA, and protein biosynthesis, demonstrated that the PureB, a
peptide of the puroindoline family, inhibits the transcription pro-
cess and, therefore, the translation process. However, it is still
unknown how indolicidin and puroindoline bind to the nucleic
acid. Probably, the positive charges of these peptides interact
with the phosphate groups of the nucleic acids (Park et al., 1998;
Uyterhoeven et al., 2008).
Cathelicidins comprise a family of mammalian proteins with
a wide spectrum of antimicrobial activity. One representative is
PR-39, which is involved in several cellular processes, including
wound repair, chemoattraction, angiogenesis, and inﬂammation
(Zanetti, 2004; Kaneider et al., 2007). This AMP rapidly crosses
the cell, without causing membrane damage, and blocks DNA
and protein synthesis in bacteria (Boman et al., 1993; Chan et al.,
2001; Bals and Wilson, 2003). In addition, some studies propose
that PR-39 acts as a noncompetitive and reversible inhibitor of
the 20S proteasome, blocking the degradation of NF-κB inhibitor,
IκBα. As a result, NF-κB–dependent gene expression is suppressed
thereby attenuating inﬂammation (Gao et al., 2000; Anbanandam
et al., 2008). The multiple effects of PR-39 in the target cell might
reﬂect its ability to selectively bind to cytosolic proteins containing
SH3 domains (Kaneider et al., 2007).
Another family of cationic peptides with potent antimicrobial
activity is the bactenecins, present in bovine neutrophil granules.
Two members of this family, Bac5 and Bac7, act by increasing
membrane permeability and inhibiting protein and RNA synthe-
sis in E. coli and Klebsiella pneumoniae (Skerlavaj et al., 1990).
Human neutrophils also produce large amounts of AMPs, such as
defensins. Besides the ability to permeabilize cell membranes, the
human defensinHPN-1 inhibits nucleic acid and protein synthesis
in E. coli (Lehrer et al., 1989). More recently it was proposed that
this AMP also targets the cell wall synthesis by binding to lipid
II precursor (de Leeuw et al., 2010). These data support the idea
that a single AMP can have multiple mechanisms of action that
simultaneously contribute for microorganism death.
Microcins, a group of AMPs produced by some enterobacteria,
can also inhibit intracellular targets. Microcin C (McC) is a non-
hydrolyzable aminoacyl adenylate that is imported into bacterial
cells by an outer-membrane porin and an inner-membrane ABC
(ATP-binding-cassette) transporter. Once in the cytoplasm, McC
inhibits an essential aminoacyl-tRNA synthetase (Nocek et al.,
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2012; Rebuffat, 2012). Microcidin B17 is a modiﬁed bacterial pep-
tide that targets DNA gyrase, with subsequent inhibition of DNA
replication (Collin et al., 2013). A single mutation in DNA gyrase
seems to be enough for bacterial resistance (del Castillo et al.,
2001). Microcidin B17 penetration into bacterial cell is facilitated
by the inner-membrane protein SbmA (Mathavan and Beis, 2012),
which also helps microcidin J25 to cross the cell envelope, where
it binds to the RNA polymerase, inhibiting bacterial transcription
(Mathavan and Beis, 2012; Rebuffat, 2012). Despite using different
mechanisms of action, most microcins employ the “Trojan-horse”
strategy, interacting with a bacterial component that facilitates
their active transport into the cell. Once inside de cell, the trans-
port component is removed, and the microcin peptide is released
to bind to its target (Rebuffat, 2012; Severinov and Nair, 2012).
INDUCTION OF CELL DEATH
Cell death occurs mostly in a programmed form, known as apop-
tosis, or in anunordered and accidentalmanner, known as necrosis
(Kanduc et al., 2002). Although some mechanisms that cause the
cell death are not clear yet, the importance of the caspase cascade in
the induction of apoptosis is well known (Fink andCookson,2005;
Chowdhury et al., 2006). These proteases, in particular caspase-3,
catalyze reactions that induce a rapid disarrangement in signaling,
homeostatic and repair enzymes, killing the cell (Nicholson and
Thornberry, 1997).
Other signals have been described to provoke apoptosis and
other mechanisms of death. Bortner and Cidlowski report that,
when the concentration of intracellular potassium (K+) is normal,
the cell death process is repressed by the suppression of the caspase
cascade and inhibition of the apoptotic nucleases activity. Thus,
the efﬂux of K+could prompt cell apoptosis (Bortner and Cid-
lowski, 1999). In the same way, calcium ions (Ca2+) and reactive
oxygen species (ROS) work as pro-apoptotic second messengers
(Chowdhury et al., 2006). These signals inﬂuence the mitochon-
drial homeostasis that activate the caspase cascade by releasing the
cytochrome c (Li et al., 1997).
Currently, the number of studies in this area has increased due
to the high frequency of various types of cancer. In this sense, the
comprehension of these signals could improve the development of
anti-tumoral drugs that could prevent the growth of tumors. Sev-
eral reports have described antitumor activity for different AMPs.
Magainin, a cationic peptide, induces apoptosis by increasing the
levels of ROS and the caspase-3 activity inHL-60 cells, a cancer cell
line from acute promyelocytic leukemia (Cruz-Chamorro et al.,
2006).With the same cell line, other peptide, tachyplesin, that has a
disulphide brigde and is stabilized in a β-hairpin structure, induces
apoptosis by modifying the potassium intracellular concentration
independent of caspase activation (Zhang et al., 2006).
With an erythro-leukemia cell line (K562), four β-hairpin
AMPs (gomesin, protegrin, tachyplesin, and polyphemusin II)
were tested and, despite of having the same structure, these
peptides showed different intracellular mechanisms of cell death
induction (Paredes-Gamero et al., 2012). Gomesin, for example,
induce K562 cells apotosis by phosphatidylserine externalization
and caspase-3 activation, with no cell membrane permeabilization
(Paredes-Gamero et al., 2012), while in B16 melanoma, SH-
SY5Y neuroblastoma and PC12 pheochromocytoma cells it causes
apoptosis inducing Ca+-dependent membrane permeabilization
(Soletti et al., 2010). On the other hand, protegrin provokes cell
death inducing a necrosis process by the increase of Ca+ levels
(Paredes-Gamero et al., 2012). Paredes-Gamero et al. also demon-
strated that themechanism of action of these four β-hairpinAMPs
depend on their concentration correlated to their EC50values. At
low concentrations these peptides induced different intracellular
mechanisms of cell death, as mentioned above. However, at high
concentrations, these peptides interact with the membrane and
form pores, killing the cell. The mechanism of its interaction to
mammalian cell surface is not clear and does not ﬁt to the mod-
els described above, since eukaryotic cells are quite different from
bacterial cells. Finally, this corroborate that the structure of the
peptide is not the only factor that determines the mechanism of
action in a cell. Furthermore, the concentration used in an experi-
ment could change the peptide interaction with the cell target and
its death.
Similar to these antitumor peptides, some antifungal pep-
tides could also induce fungal cell death by apoptosis, necrosis,
or other mechanisms (van der Weerden et al., 2013). PvD(1),
a plant defensin from Phaseolus vulgaris seed, is active against
Candida albicans and Fusarium oxysporum, a human and a plant
pathogen, respectively (Mello et al., 2011). This peptide kills the
fungal cell by membrane permeabilization and the induction of
oxidative stress damage, with the production of ROS and nitric
oxide (NO;Mello et al., 2011). The link between endogenous ROS
levels and apoptosis is also described to another plant defesin
HsAFP1 (Aerts et al., 2011). This peptide could be found in coral
bell seeds (Heuchera sanguinea) and inhibits several pathogenic
fungi, such as C. albicans (Osborn et al., 1995; Thevissen et al.,
2007). Although the membrane target has not been identiﬁed yet,
but inside the cell this defensin induces several pro-apoptotics sig-
nals, such ROS accumulation, phosphatidylserine externalization,
and DNA fragmentation, provoking cell death (Aerts et al., 2011).
To better understand the resistance against AMPs, in the next
section, we will focus on this important issue.
MAIN MECHANISMS OF RESISTANCE TO AMPS IN
BACTERIA
As discussed in the previous section we are now experiencing a
rapid increase in the number of alternative mechanisms for AMPs
microbial killing, showing that these molecules are more versatile
than we have imagined. On the other hand, in spite of the cres-
cent number of described AMPs active against multiple species of
pathogenic organisms, several studies are also showing different
strategies of natural or induced resistance to AMPs among differ-
ent bacterial species, pointing us to the co-evolution of AMPs and
AMP-resistance mechanisms (Peschel and Sahl, 2006). Although
fungal species also present mechanisms of AMP resistance in the
following sections we will focus on mechanisms of resistance in
bacteria. In general, AMP resistant bacteria have developed mul-
tiple and frequently overlapping strategies of resistance, normally
controlled by coordinated stress responses regulated by operons.
Themost common resistancemechanisms involve changes in bac-
terial cell surface and blockage of the AMP access to their targets
by affecting its binding and/or its penetration into the cells and
will be discussed in the following sections.
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SURFACE REMODELING
Gram-positive and Gram-negative bacteria modify their cell
wall components to reduce the net negative charge of their
surfaces. One strategy in Gram-negative bacteria is masking
the negative charge of the LPS lipid A by adding amine-
containing compounds such as ethanolamine and 4-amino-4-
deoxy-T-arabinose (Ara4N). It has been described that differences
in polymyxin susceptibility between Vibrio cholerae O1 El Tor
and classical biotypes could be explained by the ability of V.
cholerae O1 El Tor to modify the lipid A anchor with glycine
and diglycine residues (Hankins et al., 2012). These authors
have also shown that the enzymes required for glycine addi-
tion are similar to the Gram-positive system for D-alanylation
of teichoic acids. In addition to the binding of Ara4N to
phosphates of lipid A, palmitoylation of lipid A also pro-
motes resistance to AMPs. Salmonella sp., E. coli, Yersinia
enterocolitica, and other enteric bacteria increase lipid A acy-
lation in response to activation of the Pho-P-PhoQ regu-
lon. On the other hand, mutants in the pathway responsible
for this modiﬁcation revealed increased permeability to AMPs
(Guo et al., 1998).
Interestingly, the surface modiﬁcation leading to cationic AMP
resistance can occur in response to the presence of the cationic
AMP itself. S. enterica serovar typhimurium (S. typhimurium) uses
the two-component regulatory system PhoP-PhoQ and PmrA-
PmrB to sense the presence of environmental factors in the host
tissues such as CAMPs, which results in the activation of the
enzymes responsible for LPS modiﬁcation and CAMP resistance.
In this case, when activated, the operon regulates the synthe-
sis and attachment of positively charged Ara4N groups to lipid
A. The surface of S. typhimurium cells growing in vitro in LB
broth or on plates mainly present unmodiﬁed LPS while the
highly modiﬁed version of LPS is predominant when the cells
are grown in vivo (Strandberg et al., 2012). PhoP-PhoQ and
PmrA-PmrB systems are also activated in Pseudomonas aerug-
inosa in response to AMPs or low concentrations of divalent
cations resulting in the resistance to polymyxin B and other
CAMPs (McPhee et al., 2003; Moskowitz et al., 2004; McPhee
et al., 2006). Another pathogen, Y. pestis, also depends on a two-
component regulatory system to respond to AMPs, since mutants
of the PhoPQ pathway had decreased intracellular survival in
PMN (O’Loughlin et al., 2010). Similarly, Pietiainen et al. found
that, in S. aureus, AMPs induce the expression of two operons
VraSR cell-wall regulon and the vraDE operon. Among the genes
activated in this response there was an ABC transporter, a possi-
ble peptidase and a small unknown protein. The vraDE seemed
to be involved mainly in bacitracin resistance, while VraSR was
shown to act in the resistance to several cell wall-active antibiotics
and other antimicrobial agents including AMPs (Pietiainen et al.,
2009).
Helicobacter pylori is a Gram-negative bacterium that col-
onizes the stomach mucosa and can cause peptic ulcer
and gastric cancer. The strategy of these bacteria to avoid
AMPs consists in the dephosphorylation of the lipid A
fraction of LPS followed by the addition of a phospho-
ethanolamine group (Tran et al., 2006). Cullen et al. showed
that H. pylori mutants that are unable to remove the
phosphate groups are highly sensitive to polymyxin and
also more readily recognized by the innate immune Toll-like
receptor 4 (Cullen et al., 2011).
The main strategy used by Gram-positive bacteria to reduce
the negative charges in their surface is the D-alanylation of tei-
choic acids, mediated by the dlt operon and/or the incorporation
of T-lysine into PG by themprF gene product (Kristian et al., 2005;
Andra et al., 2011; Saar-Dover et al., 2012). The dlt operon medi-
ates the esteriﬁcationof teichoic acidswithD-alanyl esterswhile the
membrane protein MprF modiﬁes PG by the enzymatic transfer
of L-lysine that changes the net charge of this lipid to become pos-
itive (Neuhaus and Baddiley, 2003; Andra et al., 2011). Mutations
in genes of both pathways were shown to drastically increase the
susceptibility of several Gram-positive strains to AMPs (Peschel
et al., 1999; Kovacs et al., 2006; Thedieck et al., 2006; Abi Khat-
tar et al., 2009; Andra et al., 2011; McBride and Sonenshein, 2011).
Interestingly, Saar-Dover et al. suggested that themainmechanism
involved in the AMP resistance mediated by the D-alanylation is
an increase in the cell wall density impairing the penetration of
AMPs instead of a major effect on the AMP binding to bacterial
surface (Saar-Dover et al., 2012). However, further studies with
other species are necessary to conﬁrm if this mechanism can be
generalized.
The work of Shireen et al. (2013) reinforce the idea that alter-
ations in surface net charge are not always the main mechanism
of surface modiﬁcation leading to AMP resistance. They analyzed
the effects of sub-lethal concentrations of two AMP, magainin 2
and gramicidin D, on the rise of resistant strains of S. aureus, and
found that the two peptides induced different resistance strate-
gies that result in an increase of membrane rigidity (Shireen et al.,
2013).
Another surface modiﬁcation that can be related to AMP
resistance is capsule production. Capsular polysaccharide may
acts as a shield, avoiding the interactions between the micro-
bial surface and CAMPs. For example, Campos et al. (2004) have
shown that K. pneumoniae capsule makes their cells more resis-
tant to defensins, lactoferrin and polymyxin B, while acapsular
mutants bound more AMP than wild-type strains. Interest-
ingly, they also found that CPS expression is induced in the
presence of AMPs, as previously observed with antibiotic treat-
ment. Additionally to K. pneumoniae, CPS from Streptococcus
pneumoniae serotype 3 and P. aeruginosa also increased resis-
tance of a K. pneumoniae acapsular strain to polymyxin and
for α-defensin (Llobet et al., 2008). The authors suggest that
these bacteria can induce the release of capsular polysaccha-
ride in response to AMPs in order to inhibit their interaction
with their targets (Llobet et al., 2008). This phenomenon is also
observed with Neisseria meningitidis where CPS contributes to
LL-37 resistance (Jones et al., 2009). In Campylobacter jejuni,
however, capsule expression was not essential to mediate AMPs
resistance, but only to serum components. In this species, resis-
tance to α-defensins, cathelicidins (LL-37) and polymyxin B
seems to be related to lipooligosaccharides produced by this
organism, as demonstrated by the increased susceptibility of
the truncate lipooligosaccharide mutant, when compared to
the wild-type strain (Keo et al., 2011). Shielding of AMP tar-
gets is also performed by alginate, a polymer secreted by
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P. aeruginosa during bioﬁlm formation that induces changes in
AMP conformation, avoiding their interaction with microbial
membrane (Chan et al., 2004).
MODULATION OF AMP GENES EXPRESSION
The highly contagious and invasive Gram negative rod Shigella
spp. cause bacillary dysentery that can be often fatal to infants
and children. S. ﬂexneri was shown to subvert the immune system
by down-regulating the expression of innate immune response
genes, among them the genes of the cathelicidin LL-37 and the
human β-denfensin-1 (Islam et al., 2001; Sperandio et al., 2008).
This down-regulation probably facilitates bacterial adhesion and
invasion as lower levels of AMPs correlates with deeper invasion
of S. ﬂexneri toward intestinal crypts (Sperandio et al., 2008).
Several species of the genus Burkholderia are inheritably resis-
tant to AMPs. This genus includes several human pathogens
among them the Burkholderia cepacia complex, which are par-
ticularly important for causing chronic opportunistic infections
especially in patients with cystic ﬁbrosis or chronic granulomatous
disease (Mahenthiralingam et al., 2005; Loutet andValvano, 2011).
One of the explanations for the high resistance of Burkholderia sp.
to AMPs is the constitutive production of Ara4N as part of their
LPSmolecule (Cox andWilkinson, 1991; Isshiki et al., 1998; Loutet
andValvano, 2011). The other strategy used by this group is medi-
ated by the alternative sigma factor RpoE, which controls several
genes responsive to stress conditions, however the genes involved
in this process are not know yet (Flannagan and Valvano, 2008;
Loutet et al., 2011). Interestingly, RpoE was shown to be required
for B. cenocepacia polymixin B resistance at 37◦C, but not at 30◦C
(Loutet and Valvano, 2011).
Another example of modulation of host AMP production by
the pathogen was observed in experiments using K. pneumoniae
capsular mutant strains. Using acapsular mutants Moranta et al.
found that the polysaccharide capsule is also involved in the inhi-
bition of human β-defensins expression. They observed that an
acapsular mutant induced the expression of β-defensins by engag-
ing TLR 2 and 4 and activating NF-κb MAPK pathways necessary
for β-defensins expression, while the wild-type strain or LPS O
antigen mutant did not (Moranta et al., 2010).
BIOFILMS
Bioﬁlms are microbial communities consisting of cells attached to
biotic or abiotic surfaces, embedded in an exopolymeric matrix.
These structures are well known for their remarkable resistance to
diverse chemical, physical, and biological antimicrobial agents and
are one of the main causes of persistent infections. Bioﬁlms are
alsomore resistant toAMPs and this feature is linked, although not
restrict, to changes in gene expression of bioﬁlm cells, the nature
of exopolymeric matrix, and bioﬁlm architecture.
Chan et al. have shown that alginate, a polysaccharide of P.
aeruginosa biolﬁm matrix has an important role in P. aeruginosa
resistance to AMPs (Chan et al., 2004). First, alginate mimics
the microbial membrane by inducing conformational changes
in AMPs similar to those that occur during the peptide inser-
tion in the membrane bilayer. In addition, alginate also prevents
AMPs diffusion because of its ability to bind and induce peptide
aggregation, impairing their action (Chan et al., 2004, 2005).
DNA is also amajor component of the bioﬁlmmatrix. Mulcahy
et al. found that exogenous DNA chelates cations, inducing AMP
resistance to aminoglycosides and cationic AMPs in P. aeruginosa
(Mulcahy et al., 2008). The authors observed that extracellular
DNA has antimicrobial activity, but that sub-inhibitory concen-
trations of exogenous DNA induced microbial resistance. The
resistance was partially explained by the ability of DNA to chelate
several divalent cations, activating the expression of antimicrobial
resistance genes such those involved in LPS modiﬁcation and also
the release of genomic DNA, what can result in a DNA gradient
inside bioﬁlms (Mulcahy et al., 2008). Similar results were found
in a study with S. typhimurium, showing that extracellular DNA
also induced the expression of pmr genes, resulting an increased
resistance to AMPs (Johnson et al., 2013).
Moreover, Folkesson et al. established that the differential orga-
nization observed in E. coli bioﬁlms due to the presence of the
transfer plasmids is crucial for AMP resistance. Bacterial strains
lacking the transfer plasmid formed less organized bioﬁlms, which
were more susceptible to AMPs. The bioﬁlm resistance was also
dependent on a two-component regulatory system homolog to
the pmrA-pmrB. Interestingly, the resistance was not a bioﬁlm
general property, being observed only in a subpopulation of
cells within the bioﬁlm, as previously observed for P. aeruginosa
bioﬁlm resistance to colistin (Haagensen et al., 2007; Folkesson
et al., 2008).
PROTEOLYTIC DEGRADATION
Gram-positive and Gram-negative bacteria produce peptidases
and proteases that degrade CAMPs. Linear peptides are the main
target for those enzymes, since proteolytic sites are more exposed
to cleavage. The human antimicrobial peptide, LL-37, is digested
by proteases of many human pathogens, like P. aeruginosa, Ente-
rococcus faecalis, Proteus mirabilis, S. aureus, and S. pyogenes
(Schmidtchen et al., 2002; Sieprawska-Lupa et al., 2004; Johans-
son et al., 2008). The elastase of P. aeruginosa rapidly degrades
LL-37, generating early intermediate fragments presenting resid-
ual bactericidal activity when incubated with E. faecalis. However,
incubation with late digestion fragments shows no bactericidal
effect, demonstrating the complete degradation and loss of func-
tion of LL-37. Notably, elastase preferentially cleaves LL-37 regions
involved in its antimicrobial activity (Schmidtchen et al., 2002).
Themetalloprotease ZapAproduced byP.mirabilis is an impor-
tant virulence factor involved in the degradation of AMPs (Belas
et al., 2004). ZapA cleaves the β-defensin hBD1 and LL-37, par-
tially cleaves PG-1, and is incapable to digest hBD2, in spite of
the high similarity between hBD2 and hBD1. ZapA also cleaves
LL-37 preferentially on sites inside the antimicrobial domains of
this cathelicidin, as already described (Schmidtchen et al., 2002).
ZapA digestion is not speciﬁc to AMPs, since it also degrades
other molecules, like cell matrix components (actin, collagen,
ﬁbronectin, laminin), antibodies (IgA and IgG), and complement
C1q and C3 (Belas et al., 2004). On the other hand, mutants of
ZapA are no more susceptible to those AMPs than the wild-type
strain, indicating that P.mirabilis may usemultiplemechanisms to
avoid the AMPs action. Similarly, culture supernatants of Porphy-
romonas gingivalis efﬁciently degrades α- and β-defensins (Carlisle
et al., 2009) and other AMPs, but resistance to those peptides
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seems to be independent of the proteolytic activity (Bachrach et al.,
2008).
Species of Bacillus that produce metalloproteases rapidly
degrade LL-37 and are more resistant to this CAMP than non pro-
ducing species. Culture supernatants of B. anthracis also degrade
LL-37 and are shown to increase LL-37 resistance in B. subtilis, a
hypersensitive species, when grown together (Thwaite et al., 2006).
Another example of protease-mediated AMP resistance occurs
in Burkholderia cenocepacia, which produces two zinc-dependent
metalloproteases (ZmpA e ZmpB) that inactivate different AMPs
(Kooi and Sokol, 2009). Other proteases seem tomediate the resis-
tance to lactoferrin B in E. coli and S. aureus (Ulvatne, 2002),
like DegP in E. coli, a protease that also acts as a heat-shock
protein.
Some members of the omptins family of outer membrane pro-
teases present in Gram-negative bacteria are reported to mediate
and contribute to resistance to AMPs. The PgtE protease of S.
enterica Serovar typhimurium and CroP protease of Citrobacter
rodention promote resistance to α-helical peptides (Guina et al.,
2000; Le Sage et al., 2009). OmpT has an important role in the
resistance of E. coli to protamine and urinary cationic peptides
(Stumpe et al., 1998; Hui et al., 2010). In enterohemorrhagic E.
coli (EHEC),OmpT contributes to the degradation of LL-37more
efﬁciently than in enteropathogenic E. coli (EPEC). The difference
between EHEC OmpT and EPEC OmpT in providing defense
against AMPs is due to the differences in the regulation of ompT
genes in a promotor dependent manner, resulting in high lev-
els of ompT transcripts and OmpT protein in EHEC (Thomassin
et al., 2012). A posterior study with uropathogenic E. coli (UPEC)
demonstrated that UPEC OmpT can cleave and protect the mem-
brane from LL-37, but only when is expressed in high levels
(Brannon et al., 2013), similar to those reported by Thomassin
et al. (2012) for EPEC. Therefore, UPEC OmpT is not essential
to LL-37 resistance. These data suggest that the role of OmpT in
resistance to AMPs is speciﬁc to each pathogen.
In order to avoid killing by AMPs, pathogens may form com-
plexes that retain their own proteases near the bacterial surface
(Nyberg et al., 2004). This study shows that the host proteinase
inhibitor α2-macroglobulin (α2−M) binds with high afﬁnity to
GRAB, a protein attached to S. pyogenes cell wall. The α2−M, on
theother hand, traps the SpeBprotease secretedby thebacteria, but
SpeB retains the ability to degrade LL-37 and, more interestingly,
its proteolytic activity against that AMP molecule is enhanced.
EFFLUX PUMPS
Efﬂux pumps are energy-dependent transporters that extrude
toxic compounds, including antibiotics, being one of the major
mechanisms by which microbial pathogens resist to different
classes of antibiotics (Piddock, 2006; Poole, 2007). Kupferwasser
et al. (1999) demonstrated that a naturally occurring plasmid
containing qacA gene, which encodes a proton motive force-
dependentmultidrug efﬂux pump, confers resistance to tPMP-1 in
S. aureus, while constructions with deletions that compromise the
qacA gene abolish tPMP-1 resistance. The qacA-mediated resis-
tance seems to be speciﬁc to tPMP-1, because the expression of
qacA did not confer resistance to other AMPs. It is possible that
the efﬂux function of QacA protein itself is not responsible for
the resistance to tPMP-1, but the alterations on the cytoplasmic
membrane of strains expressing qacA. On the other hand, in Neis-
seria gonorrhoeae and N. meningitidis, the energy-dependent Mrt
efﬂux pump mediates the resistance to antibacterial peptides PG-
1, PC-8, LL-37, and TP-1 (Shafer et al., 1998; Tzeng et al., 2005).
Notably, this pump recognizes structurally unrelated AMPs, such
as PG-1, which folds into a β-sheet conformation, and LL-37,
that assumes n α-helical structure. The importance of Mrt efﬂux
pump system to avoid AMPs-killing during in vivo infections by
N. gonorrhoeae was demonstrated by Jerse et al. (2003) whereMtr-
CDE mutants were more susceptible to the host immune system.
Warner et al. also showed that mutations upstream of mrtC, on
the promoter of the mtrR gene encoding a repressor for MtrCDE,
or in the binding site of MrtR, confer more resistance to LL-37
and CRAMP-8, a murine analogous to LL-37, by increasing the
levels of MrtE and mrtCRNA stability (Warner et al., 2008). These
mutants were also more ﬁtted in vivo than wild-type strains, high-
lighting the importance of this pump in evasion of the immune
system.
Resistance to polymyxin B in Y. enterocolitica and K. pneumo-
nia involves a system composed of two proteins, RosA/RosB and
AcrAB, respectively (Bengoechea and Skurnik, 2000; Padilla et al.,
2010). The dissipation of the proton-motive force by the addition
of Carbonyl cyanide m-chlorophenyl hydrazone CCCP reduced
the resistance to polymyxin B, highlighting the importance of
the energy-driven efﬂux pump of AMPs in resistance to these
molecules. In Y. enterocolitica, RosA functions as a CAMP proton
motive force-dependent efﬂux pump, while RosB has a potassium
antiporter activity, involved in the regulation of intracellular pH,
which is linked to CAMPs resistance by acidiﬁcation of the cyto-
plasm. Both, RosA and RosB, are required for resistance to CAMPs
and the presence of these defense molecules increases the expres-
sion of the ros locus, as observed in S. pneumoniae LL-37 resistance,
mediated by MefE/Mel efﬂux pump (Zahner et al., 2010). Simi-
larly, the protein TrkA of the potassium transport complex Trk
is required for CAMP resistance in Vibrio vulniﬁcus (Chen et al.,
2004). It is hypothesized that protamine forms channels through
whichK+ leaks from the cell; then, the high-rateK+uptake systems
pump potassium inside the cell, preventing bacterial death until
the protamin is degraded by extracellular proteases. Likewise, sapG
mutants, a S. typhimurium gene that encodes a protein involved in
potassium transport higlhy homologous to TrkA, exhibited hyper-
sensitivity to protamin (Parra-Lopez et al., 1994). On the other
hand, the overexpression of AcrAB, MexAB and NorA pumps in
E. coli, P. aeruginosa, and S. aureus, respectively, did not increase
resistance to CAMPs suchHNP-1,HNP-3,HD-5,HBD-2,HBD-3,
andLL-37,when compared to thewild-type strains and inactivated
mutants. These results indicate that speciﬁc efﬂux pumps extrude
speciﬁc types of AMPs (Rieg et al., 2009).
TRAPPING
Some secreted molecules can bind to and neutralize the microbi-
cidal activity of AMPs. For example, SIC proteins produced by S.
pyogenes M1 bind to several AMPs, blocking their antimicrobial
activity in the early stages of infection (Frick et al., 2003; Fernie-
King et al., 2004; Pence et al., 2010). SIC binds more efﬁciently
to LL-37 than to the defensing human neutrophil peptide HNP-1
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and SIC deﬁcient mutants are more sensitive to LL-37 than wild-
type strains. Other SIC variants from other serotypes also bind
and interfere with the antimicrobial activity from AMPs, but SIC
from M1 strain is more potent (Frick et al., 2003). In addition to
the plasminogen binding activity, Staphylokinase (SAK) from S.
aureus can also binds to HNP-1 and HNP-2. SAK induces HNPs
release from neutrophils, and the formation of a complex of SAK
and the α-defensin results in the loss of antimicrobicidal activity
of those defense molecules. This complex abrogates bactericidal
activity of HNPs in other species, when grown together.
Other trappingmolecules can be found attached to the bacterial
surface, like M1 protein from S. pyogenes. M1 mutant strains are
killed more efﬁciently by cathelicidins, LL-37 or mCRAMP than
the wild-type strain. It seems that M1 acts as a shield, binding,
and trapping the AMPs before they can reach the cell membrane
and kill the pathogen (Lauth et al., 2009). Pili also may be a trap
to AMPs. Maisey et al. (2008) reported that PilB from Group B S.
sequesters LL-37 and mCRAMP, increasing the resistance to those
peptides. GRABs also mediate an important binding mechanism
in resistance to LL-37 by S. pyogenes (Nyberg et al., 2004).
It is also described that the shedding of host molecules by pro-
teases from pathogens are involved in sequestration and resistance
to severalAMPs. For example, extracellular proteases secreted byP.
aeruginosa, and E. faecalis degrade decorin proteoglycan, produc-
ing dermatan sulphate that protects those bacteria from killing
mediated by HPN-1 through directly binding to the α-defensin
(Schmidtchen et al., 2001).
CONCLUSION
The increasing emergence of antibiotic resistance among human
pathogens has led to the search for alternatives to overcome this
alarming problem. Despite their ancient origin, only in the past
decades the study of AMPs have gained increased attention as a
promising therapeutic alternative against pathogenicmicroorgan-
isms due their broad spectrum of activity against several species of
bacteria, fungi, protozoa, and enveloped virus. Although the main
target of AMPs was previously thought to be bacterial membrane
several new and frequently, combined strategies of killing have
been described in the past decades. Resistance to these molecules
seems to be less common than to conventional antibiotics but was
selected in several pathogens during the co-evolution of host and
pathogens. A better comprehension of AMPs mode of action and
counterpart resistance mechanisms is fundamental for the design
of optimized AMPS that could be efﬁciently used as therapeutic
drugs.
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